An experimental pill to treat the Chinese coronavirus is in the works.
“The Food and Drug Administration has determined that molnupiravir, an experimental COVID-19 pill from pharmaceutical giant Merck, is effective against the virus, and the agency will now seek expert input on outstanding safety questions, including the potential for birth defects and other problems if the pill is taken during pregnancy,” reported JustTheNews.com.
“The FDA will convene publicly next week during a conference where academics and other experts will discuss the safety and efficacy of the drug,” reported JustTheNews.com
“The federal agency says its scientists have identified several potential risks from the drug, including toxicity and birth defects. Regulators will ask experts whether there should be a blanket prohibition on the pill during pregnancy, or if there are case exceptions. Pregnant women were excluded from Merck’s study. The FDA is not required to follow the group’s guidance,” according to JustTheNews.com.
“The agency has identified a concern that the Merck pill can lead to small changes in the coronavirus’ signature spike protein, which could potentially lead to dangerous new variants of the virus. Regulators noted that significantly less safety data was accumulated overall for the Merck pill than for virtually all other COVID-19 therapeutics,” reported JustTheNews.com.
To read more about this fancy new pill, click here.